ENGIMATA INC
Biotechnology - , California, United States
ENGIMATA INC Employees
ENGIMATA INC Senior Management
ENGIMATA INC Details
Engimata has a platform adjuvant technology that improves vaccine efficiency, reduces antigen dose and enhances vaccine stability outside the cold supply chain.Engimata is currently developing a vaccine against COVID-19 using its platform technology. Engimata's vaccine is cost-effective, easy to scale up, and simple to manufacture and distribute outside the cold supply chain. This increases vaccine accessibility and stability, ultimately saving cost, resources, and lives. Vaccine wastage in the supply chain due to temperature fluctuations is a major problem for current vaccines and costs the government and WHO billions of dollars every year. In order to combat COVID-19, it is crucial to overcome transportation barriers and distribute a vaccine across the world.
ENGIMATA INC Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Tag Management
Google Tag Manager
Other
Mobile Friendly
CSS and JavaScript Libraries
JQuery 2.1.1